Health State Utilities Associated with Glucose Monitoring Devices
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose monitoring is important for patients with diabetes treated with insulin. Conventional glucose monitoring requires a blood sample, typically obtained by pricking the finger. A new sensor-based system called "flash glucose monitoring" monitors glucose levels with a sensor worn on the arm, without requiring blood samples. OBJECTIVES: To estimate the utility difference between these two glucose monitoring approaches for use in cost-utility models. METHODS: In time trade-off interviews, general population participants in the United Kingdom (London and Edinburgh) valued health states that were drafted and refined on the basis of literature, clinician input, and a pilot study. The health states had identical descriptions of diabetes and insulin treatment, differing only in glucose monitoring approach. RESULTS: A total of 209 participants completed the interviews (51.7% women; mean age = 42.1 years). Mean utilities were 0.851 ± 0.140 for conventional monitoring and 0.882 ± 0.121 for flash monitoring (significant difference between the mean utilities; t = 8.3; P < 0.0001). Of the 209 participants, 78 (37.3%) had a higher utility for flash monitoring, 2 (1.0%) had a higher utility for conventional monitoring, and 129 (61.7%) had the same utility for both health states. CONCLUSIONS: The flash glucose monitoring system was associated with a significantly greater utility than the conventional monitoring system. This difference may be useful in cost-utility models comparing the value of glucose monitoring devices for patients with diabetes. This study adds to the literature on treatment process utilities, suggesting that time trade-off methods may be used to quantify preferences among medical devices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Overview on self-monitoring of blood glucose
Montagnana, M., Caputo, M., Giavarina, D., & Lippi, G. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.002 · Cited by 116
Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas
Visentin, R., Dalla Man, C., Kudva, Y. C., Basu, A., & Cobelli, C. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0192 · Cited by 113
Kerr, D., Messing, R., & Resch, A. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500635 · Cited by 8
Self-citation
Cited by
Roze, S., Isitt, J. J., Smith-Palmer, J., & Lynch, P. (2021) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s304395 · Cited by 15
“03 utility benefit was also applied owing to the avoidance of fingerstick testing, based on the findings of a study comparing flash glucose monitoring with SMBG as this method of glucose monitoring also reduces or negates the requirement for fingerstick testing.(18) This resulted in a total utility benefit of 0.”
MethodAjjan, R., Bilir, S. P., Hellmund, R., & Souto, D. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01325-w · Cited by 14
Self-citationHarris, S., Cimino, S., Nguyen, Y., Szafranski, K., & Poon, Y. (2025) · Diabetes Therapy · doi:10.1007/s13300-024-01677-5 · Cited by 12
“…of blood glucose, T1DM type 1 diabetes mellitus, T2DM type 2 diabetes mellitus Congestive heart failure 24% German real-world data; Reibis 2017 [41] Myocardial infarction 13% International real-world data; Dreyer 2016 [42] using SMBG, based on a time trade-off study conducted in the UK [62].”
Metadata
- Authors
- Matza, L. S., Stewart, K. D., Davies, E. W., Hellmund, R., Polonsky, W. H., & Kerr, D.
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2017-03
- Volume
- 20
- Issue
- 3
- Pages
- 507-511
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2208450501
- Cited by
- 44
- References
- 6
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.